Perceive Biotherapeutics Attracts $78M Series B Financing To Advance Diversified Pipeline
Amount Raised
$78 Million
Round Type
Series B
South San FranciscoBiotechnologyInvestors
Description
Perceive Biotherapeutics, a biotech company pioneering novel technologies and therapeutics in ophthalmology, today announced the closing of a $78M Series B funding round led by Johnson & Johnson Innovation – JJDC, Inc.(JJDC), joining existing Series A investor Deerfield Management and new investors Braidwell LP, the Retinal Degeneration Fund, and Catalio Capital Management, LP.
Quick answer
Perceive Biotherapeutics raised $78 Million in a Series B round, dated January 5, 2023. Investors: Catalio Capital Management, LP, Retinal Degeneration Fund and Deerfield Management. Perceive Biotherapeutics is based in South San Francisco, California, United States.
- How much did Perceive Biotherapeutics raise?
- Perceive Biotherapeutics raised $78 Million in a Series B round on January 5, 2023.
- Who invested in Perceive Biotherapeutics?
- Catalio Capital Management, LP, Retinal Degeneration Fund and Deerfield Management are named as investors in this round.
- What does Perceive Biotherapeutics do?
- Perceive Biotherapeutics is advancing a deep and diversified pipeline of targets and treatment modalities in multiple therapeutic verticals, with lead pipeline programs in ophthalmology.
- Where is Perceive Biotherapeutics based and how big is it?
- Perceive Biotherapeutics is based in South San Francisco, California, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Perceive Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- NovAb raised $300K (Seed) on February 17, 2023.
- Evofem Biosciences raised $1.4M (Seed) on February 17, 2023.
- Pathos AI raised $20M on February 17, 2023.
- CardioMech AS raised $4.5M (Seed) on February 16, 2023.
- Previa Medical raised $2.2M (Seed) on February 16, 2023.
- 1606 Corp raised $20M (Funding Round) on February 16, 2023.
Who to call at Perceive Biotherapeutics, and when
A new round usually means Perceive Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Perceive Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Perceive Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Perceive Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Perceive Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansPerceive Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.